Product Description
The global VCF market was valued at over $1.1 billion in 2024. This is expected to increase over the forecast period at a CAGR of 5.2% to reach over $1.6 billion.
The full report suite on the global market for VCF includes segments for percutaneous vertebral augmentation (PVA) and vertebroplasty.
This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET TRENDS
All regions are expected to experience growth in the VCF market over the forecast period, but the extent to which they grow differs. The Middle East is projected to have the highest growth rate, followed by Africa and Asia-Pacific. North America has the lowest forecasted growth rate over the forecast period followed by Western Europe. This can be due to the fact that the markets in North America and Western Europe are more mature compared to other regions as North America has the largest VCF market and Western Europe is third after Asia-Pacific, which has a larger population.
GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET SHARE INSIGHTS
- Medtronic held the leading position in the global VCF market in 2024. This company had close to half of the global market value. Medtronic was the leader of the market in most regions except for some countries, but its strong presence in the North American and Western European markets helped the company to establish this position.
- Stryker held the second position in the global VCF market in 2024. Stryker offers its AutoPlex™ cement mixer and delivery system and its VertaPlex™, VertaPlex HV™ and SpinePlex® bone cements. Together, these products make up Stryker’s vertebroplasty system. Stryker has its iVAS™ PVA system. The iVAS™ vertebral augmentation solution uses a stiff distal balloon catheter to provide rigidity for smooth insertion. Stryker launched its AVAflex Balloon System in 2017, helping it attain a greater share of the PVA segment. Adoption of Stryker’s PVA system has been a result of both the company’s influence in the vertebroplasty market and the lower cost of Stryker’s device compared to Medtronic’s KyphX® system. Stryker also carries the AVAmax®.
- DePuy Synthes held the third position in the global VCF market in 2024, with offerings focused on vertebroplasty and balloon kyphoplasty. Its portfolio includes the CONFIDENCE™ Spinal Cement System and VERTECEM™ V+ bone cement, designed for controlled delivery and enhanced stability during vertebral augmentation procedures. While its presence is strongest in North America and Europe, DePuy is expected to expand its global footprint through continued investment in product development and distribution.
MARKET SEGMENTATION SUMMARY
- Vertebral Compression Fracture Market – Further Segmented Into:
- Device type: Vertebroplasty and PVA.
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
